A Phase 1 Dose Escalation Study of VX-973 in Healthy Adults
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and
pharmacodynamics of single and multiple doses of VX-973 in healthy participants.